SCIEX Presents Clinical Solutions for Routine Diagnostics and Innovative Research

SCIEX (Framingham, MA, USA) announced new product introductions at AACC 2018, adding to its existing solutions and services to deliver the power of mass spectrometry to clinical laboratories performing routine diagnostic assays and innovative clinical research applications.

SCIEX announced the launch of the new Topaz Prep Station, an automated sample preparation workstation that is ideal for labs managing high daily sample volumes. The Topaz Prep Station supports the Topaz LC-MS/MS System, a Class I Medical Device designed to simplify adoption for new mass spectrometry users, while still offering the functionality needed for more advanced users.

SCIEX also announced the introduction of the new FDA-approved Vitamin D 200A Assay Kit. This kit is a locked, pre-validated assay that allows labs to perform vitamin D analysis in-house, and employs automated sample preparation on the Topaz Prep Station to deliver highly accurate results to support medical decisions and quality patient care. Together, the Topaz Prep Station and the Vitamin D 200A Assay Kit enables clinical diagnostic testing labs to increase laboratory productivity, further reduce sample preparation times and streamline workflows, provide more consistent and accurate results and minimize human error, and easily handle large sample volumes.

The Topaz System makes the move to mass spectrometry simple and efficient by providing clinical diagnostics laboratories a complete LC-MS/MS package, with an easy-to-use, intuitive user interface that allows users to build proficiency quickly. Earlier this year, SCIEX launched the Citrine MS/MS system, the front-line alternative for clinical diagnostics. With its unique combination of sensitivity and speed, the Citrine system enables trace level analysis, comprehensive panels and the measurement of both large and small molecules.

In addition to showcasing the Topaz LC-MS/MS System, the Topaz Prep Station and the Citrine MS/MS medical devices at AACC 2018, SCIEX also featured clinical research innovations and workflows that support efforts in biomarker discovery and validation, recognizing that new biomarkers today could be applied as routine diagnostic assays of the future. SCIEX's partnership with Phenomenex, a global leader in separation science techniques, also leads to a wide range of workflow and data quality-enhancing solutions, which were displayed at the event.

“We are excited to offer our latest developments, designed to bring the reliability and accuracy of LC-MS/MS to clinical labs,” said Aaron Hudson, Vice President of Global Marketing and Clinical Diagnostics at SCIEX. “While supporting our rapidly growing portfolio of innovative solutions, SCIEX aspires to provide cutting edge technology while reducing the complexity for the user.”